INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2015

Newer weight management medications aid weight loss and maintenance, with varying positive and potentially negative cardiometabolic effects.

Since the 1980s, obesity prevalence has nearly doubled globally, with treatments including lifestyle modification, medications, and surgery. This review discusses the mechanisms and cardiometabolic implications of newly approved next-generation weight management medications. These medications demonstrate efficacy in initial weight management and long-term maintenance, while showing varying effects on diabetes and cardiovascular risks.

Study type
Narrative review
Who was studied
Individuals with obesity
What was measured
Weight management, diabetes risk, and cardiovascular disease risk

THE PAPER

Next generation of weight management medications: implications for diabetes and CVD risk.

Wharton S, Serodio KJ. Curr Cardiol Rep, 2015.

PubMed 25894803 ↗DOI 10.1517/14712598.2011.619974 ↗

Heart & arteriesDiabetes & blood sugarWeight & appetite

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.